Integrated genomics of ovarian xenograft tumor progression and chemotherapy response.
about
Insulin-Sensitizers, Polycystic Ovary Syndrome and Gynaecological Cancer RiskEfficacy of a non-hypercalcemic vitamin-D2 derived anti-cancer agent (MT19c) and inhibition of fatty acid synthesis in an ovarian cancer xenograft modelPlasma 25 hydroxyvitamin D level and blood gene expression profiles: a cross-sectional study of the Norwegian Women and Cancer Post-genome CohortPT19c, Another Nonhypercalcemic Vitamin D2 Derivative, Demonstrates Antitumor Efficacy in Epithelial Ovarian and Endometrial Cancer Models.RNA-based ovarian cancer research from 'a gene to systems biomedicine' perspective.The novel ZIP4 regulation and its role in ovarian cancer.
P2860
Integrated genomics of ovarian xenograft tumor progression and chemotherapy response.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Integrated genomics of ovarian xenograft tumor progression and chemotherapy response.
@ast
Integrated genomics of ovarian xenograft tumor progression and chemotherapy response.
@en
type
label
Integrated genomics of ovarian xenograft tumor progression and chemotherapy response.
@ast
Integrated genomics of ovarian xenograft tumor progression and chemotherapy response.
@en
prefLabel
Integrated genomics of ovarian xenograft tumor progression and chemotherapy response.
@ast
Integrated genomics of ovarian xenograft tumor progression and chemotherapy response.
@en
P2093
P2860
P356
P1433
P1476
Integrated genomics of ovarian xenograft tumor progression and chemotherapy response.
@en
P2093
Alexander S Brodsky
Andrew Fischer
Ashley Stuckey
Benjamin J Raphael
Daniel H Miller
Rakesh K Singh
Sara Hillenmeyer
P2860
P2888
P356
10.1186/1471-2407-11-308
P407
P577
2011-07-22T00:00:00Z
P5875
P6179
1022721588